Publicaciones en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (22)

2023

  1. Correction: Vitamin C and folate status in hereditary fructose intolerance (European Journal of Clinical Nutrition, (2022), 76, 12, (1733-1739), 10.1038/s41430-022-01178-3)

    European Journal of Clinical Nutrition

2022

  1. SARS-CoV-2 infection in early first-trimester miscarriages: a prospective observational study

    Reproductive BioMedicine Online, Vol. 44, Núm. 1, pp. 127-130

  2. Vitamin C and folate status in hereditary fructose intolerance

    European Journal of Clinical Nutrition, Vol. 76, Núm. 12, pp. 1733-1739

2021

  1. Compound endoscopic morphological features for identifying non-pedunculated lesions ≥20 mm with intramucosal neoplasia

    Cancers, Vol. 13, Núm. 21

  2. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women

    Viruses, Vol. 13, Núm. 1

  3. The association between SARS-CoV-2 infection and preterm delivery: a prospective study with a multivariable analysis

    BMC Pregnancy and Childbirth, Vol. 21, Núm. 1

  4. Transferrin isoforms, old but new biomarkers in hereditary fructose intolerance

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2020

  1. The Galleria mellonella infection model as a system to investigate the virulence of Candida auris strains

    Pathogens and Disease, Vol. 78, Núm. 9

  2. Vertical cutoff methods in serum protein electrophoresis for the measurement of monoclonal protein concentrations: Which is best?

    Clinica Chimica Acta, Vol. 510, pp. 573-580

2019

  1. Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps

    Gastroenterology, Vol. 156, Núm. 1, pp. 75-87

  2. Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs

    Journal of Medical Microbiology, Vol. 68, Núm. 9, pp. 1353-1358

  3. Component-resolved diagnosis in allergic disease: Utility and limitations

    Clinica Chimica Acta, Vol. 489, pp. 219-224

  4. Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386

  5. Secukinumab for pyoderma gangrenosum: A case report

    Medicina Clinica

2016

  1. A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia

    Hematological Oncology, Vol. 34, Núm. 2, pp. 84-92

2015

  1. A low frequency of losses in 11q chromosome is associated with better outcome and lower rate of genomic mutations in patients with chronic lymphocytic leukemia

    PLoS ONE, Vol. 10, Núm. 12

2014

  1. Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia

    BioMed Research International, Vol. 2014

2012

  1. Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14

    PLoS ONE, Vol. 7, Núm. 11

2005

  1. Specific dose-dependent damage of Lieberkühn crypts promoted by large doses of type 2 ribosome-inactivating protein nigrin b intravenous injection to mice

    Toxicology and Applied Pharmacology, Vol. 207, Núm. 2, pp. 138-146

2004

  1. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: A randomized, double-masked trial

    Clinical Gastroenterology and Hepatology, Vol. 2, Núm. 4, pp. 301-308